Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.FDA accepts acromegaly drug filing from Ipsen
This acceptance signifies the start of the review process of the new drug application with a “prescription drug user fee act” goal date set for 30 August 2007.
This acceptance signifies the start of the review process of the new drug application with a “prescription drug user fee act” goal date set for 30 August 2007.
Since the last data sweep was completed in November 2006, the monitoring board advised the company to conduct a further data sweep to bring the survival data current
The agreement is currently with the Commissioners of the Federal Trade Commission for final approval and is expected to be endorsed and finalized during the course of this
November 2006 saw Arrow’s first hepatitis C compound, A-831, enter phase I trials. Both compounds target the novel NS5a protein but have completely different chemical structures and bind
Peregrine has established the wholly foreign-owned enterprise in Beijing and is one of the latest pharmaceutical companies to tap into the expanding Chinese market. “China therefore represents an
Replicated in four distinct ethnic groups, SORL1 is only the second gene discovered for late-onset Alzheimer’s. APOE, the first gene, was identified in 1993. The researchers describe how
Roswell Park believes the partnership could grant cancer patients early access to promising new treatments and provide a commercial development pathway for new discoveries. Roswell Park and various
Under the agreement, Chromos will engineer cell lines for the expression of a monoclonal antibody for Genitope using the ACE System. The financial details of the agreement were
The researchers have discovered a specific genetic trigger that makes HIV hibernate but awaiting an opportunity to re-emerge. They studied an HIV protein called Tat, which plays a
“With the approval for the treatment of OCD, Cipralex is now approved for the treatment of all major anxiety indications and depression,” said senior vice president Anders Gersel